Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Ferry

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|February 28, 2003
Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in childrenVasundhara Tolia, George Ferry, Thirumazhisai Gunasekaran, et al.
Inflammatory Bowel Diseases|January 7, 2010
Phase I trial of sargramostim in pediatric Crohn's diseaseJudith R Kelsen, Joel Rosh, Mel Heyman, et al.
Inflammatory Bowel Diseases|April 3, 2012
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseasesR Alan Harris, Dorottya Nagy-Szakal, Natalia Pedersen, et al.
Inflammatory Bowel Diseases|May 4, 2005
Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortiumDouglas A Jacobstein, Jonathan E Markowitz, Barbara S Kirschner, et al.
The Journal of Pediatrics|January 13, 2005
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registryMelvin B Heyman, Barbara S Kirschner, Benjamin D Gold, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2009
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACHWallace Crandall, Jeffrey Hyams, Subra Kugathasan, et al.
Gastroenterology|February 28, 2007
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in childrenJeffrey Hyams, Wallace Crandall, Subra Kugathasan, et al.
Current Medical Research and Opinion|January 19, 2011
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extensionJeffrey Hyams, Thomas D Walters, Wallace Crandall, et al.
Inflammatory Bowel Diseases|September 7, 2006
Challenges in pediatric inflammatory bowel diseaseAthos Bousvaros, Francisco Sylvester, Subra Kugathasan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pediatric Gastroenterology and Nutrition|February 28, 2003
Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in childrenVasundhara Tolia, George Ferry, Thirumazhisai Gunasekaran, et al.
Inflammatory Bowel Diseases|January 7, 2010
Phase I trial of sargramostim in pediatric Crohn's diseaseJudith R Kelsen, Joel Rosh, Mel Heyman, et al.
Inflammatory Bowel Diseases|April 3, 2012
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseasesR Alan Harris, Dorottya Nagy-Szakal, Natalia Pedersen, et al.
Inflammatory Bowel Diseases|May 4, 2005
Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortiumDouglas A Jacobstein, Jonathan E Markowitz, Barbara S Kirschner, et al.
The Journal of Pediatrics|January 13, 2005
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registryMelvin B Heyman, Barbara S Kirschner, Benjamin D Gold, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2009
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACHWallace Crandall, Jeffrey Hyams, Subra Kugathasan, et al.
Gastroenterology|February 28, 2007
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in childrenJeffrey Hyams, Wallace Crandall, Subra Kugathasan, et al.
Current Medical Research and Opinion|January 19, 2011
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extensionJeffrey Hyams, Thomas D Walters, Wallace Crandall, et al.
Inflammatory Bowel Diseases|September 7, 2006
Challenges in pediatric inflammatory bowel diseaseAthos Bousvaros, Francisco Sylvester, Subra Kugathasan, et al.
Pageof 1